Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
|
CN |
|
Tungsten West PLC
F:540
|
UK |
|
R
|
Radici Pietro Industries & Brands SpA
MIL:RAD
|
IT |
|
Vicinity Motor Corp
XTSX:VMC
|
CA |
|
Invibes Advertising NV
PAR:ALINV
|
BE |
|
Doganlar Mobilya Grubu Imalat Sanayi ve Ticaret AS
IST:DGNMO.E
|
TR |
|
L
|
Li-Metal Corp
CNSX:LIM
|
CA |
|
Decmil Group Ltd
ASX:DCG
|
AU |
|
N
|
Novacon Technology Group Ltd
HKEX:8635
|
HK |
|
Greenbriar Capital Corp
XTSX:GRB
|
CA |
|
C
|
China Bohai Bank Co Ltd
HKEX:9668
|
CN |
|
O
|
Orange County Bancorp Inc
NASDAQ:OBT
|
US |
Bankruptcy Probability
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
|
13.8B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd has total debt of 14.7m CNY. This includes both short-term (5m CNY) and long-term (9.7m CNY) debt.
You can find a full breakdown on its Balance Sheet.
